Literature DB >> 11844674

Studies on quinazolinones as dual inhibitors of Pgp and MRP1 in multidrug resistance.

Shouming Wang1, Hamish Ryder, Ian Pretswell, Paul Depledge, John Milton, Timothy C Hancox, Ian Dale, Wendy Dangerfield, Peter Charlton, Richard Faint, Rory Dodd, Stephanie Hassan.   

Abstract

The syntheses and SAR studies of various quinazolinone compounds are described for the dual inhibition of Pgp and MRP1 in multidrug resistance.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11844674     DOI： 10.1016/s0960-894x(01)00804-6

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN： 0960-894X            Impact factor:   2.823


  2 in total

1.  Synthesis of some new tricyclic 4(3H)-quinazolinone derivatives.

Authors:  E Jafari; G A Khodarahmi; G H Hakimelahi; F Y Tsai; F Hassanzadeh
Journal:  Res Pharm Sci       Date:  2011-07

2.  Cytotoxic Evaluation of Some Fused Pyridazino- and Pyrrolo-quinazolinones Derivatives on Melanoma and Prostate Cell Lines.

Authors:  Golnaz Vaseghi; Elham Jafari; Farshid Hassanzadeh; Shaghayegh Haghjooy-Javanmard; Nasim Dana; Mahmoud Rafieian-Kopaei
Journal:  Adv Biomed Res       Date:  2017-06-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.